Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBAug 23, 2021 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine …
WEBJun 25, 2022 · Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase against Omicron Geometric mean ratios …
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
WEBOct 21, 2021 · In the trial, a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series restored vaccine protection against COVID-19 to the high levels achieved after the second dose, showing a relative vaccine efficacy of 95.6% when compared to those who did not receive a booster.
FDA Approves First COVID-19 Vaccine
WEBFDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
WEBAug 23, 2021 · The Food and Drug Administration on Monday granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and older, making it the first to move beyond emergency-use status in...
CDC identifies possible safety issue with Pfizer’s updated ... - CNN
WEBJan 13, 2023 · The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech but that it is unlikely to...
FDA grants full approval to Pfizer's Covid vaccine - NBC News
WEBAug 23, 2021 · The Food and Drug Administration granted full approval to Pfizer-BioNTech's two-dose vaccine Monday for people ages 16 and up, making it the first Covid-19 vaccine to pass this final...
FDA Takes Action on Updated mRNA COVID-19 Vaccines to …
WEBSep 11, 2023 · Authorization of Pfizer-BioNTech COVID-19 Vaccine for emergency use in individuals 6 months through 11 years of age to include the 2023-2024 formula.
Why Pfizer's FDA Approval Matters And What It Means For Vaccine ...
WEBAug 24, 2021 · The FDA announced the Pfizer vaccine is the first in the U.S. that is now fully approved. Here's what that means for vaccine mandates and convincing vaccine-hesitant people to get vaccinated.
- Some results have been removed